Parvathi Ranganathan, PhD
College of Medicine
Dr. Ranganathan, PhD is a member of the Leukemia Research Program at the OSUCCC-James.
Dr. Ranganathan's primary research interest is to study the immunobiology of acute Graft-Versus-Host Disease (aGVHD) with the goal of developing selective immune suppression strategies that abrogate aGVHD while maintaining T-cell responses needed to preserve the beneficial graft-versus leukemia (GVL) effect. In addition, she studies the immunomodulatory role of cellular and circulating non-coding RNAs such as microRNAs, long non-coding RNAs and circular RNAs with emphasis on their roles in aGVHD pathogenesis. A second focus of her research is to develop novel targeted therapies in acute myeloid leukemia (AML).
Education and Background
PhD, University of Arizona
Tucson, AZ (USA)
Biomedical Research Tower 411
460 W 12th Ave, Columbus, OH 43210